Stephen R Broderick MD MPHS
@SBroderickMD
Followers
662
Following
3K
Media
23
Statuses
310
Husband, Father, Surgeon, Cancer Researcher and Advocate. Johns Hopkins Thoracic Surgery Sidney Kimmel Cancer Center
Joined June 2016
Enjoyed working on the CME activity with @JustinGainor and #AiCME !#GetYourAnswerInCME
https://t.co/sTKxFyz0Ku
0
0
4
Thanks for sharing Gavitt — necessity of pneumonectomy should not disqualify for patients from neoadjuvant. #itsos2025
@SBroderickMD gives super interesting deep dive into the outcomes and details of patients undergoing pneumonectomy (even right side). @LindaMThoracic discussing points to lack of radiation preop, which in prior studies was a/w postop ARDS and worse outcomes post pneumonectomy
1
6
21
The first #ITSOS2025 plenary on Evolving Treatment Paradigms in Operable #NSCLC is getting started in the Pacific Ballroom with an introduction by @JonesDavid2013 of @MSKCancerCenter and our first Giant's Lecture by @DouglasEWood1.
0
3
12
Looking forward to #DCLung25!
Make plans for #DCLung25 - Saturday, October 4th - Washington DC - a one-day @IASLC endorsed comprehensive lung cancer conference! Dr. Stephen Broderick @SBroderickMD joins to provide surgical perspective on early stage NSCLC. Register today! https://t.co/OJz1a1lAHb
1
1
8
Deadline for @AATSHQ #ITSOS2025 abstracts tomorrow This is one of the best thoracic surgical oncology meetings of the year. Get your abstracts in! See you in Boston this September
0
7
40
Dr. @FordePatrick presents final OS results from CheckMate 816 at #ASCO25. Adding nivolumab to 3 cycles of neoadjuvant chemotherapy for resectable NSCLC improves OS with HR 0.72 and 5y OS rate 65% vs 55%. Effect greater in PDL1+ (HR 0.51) than PDL1 negative (HR 0.89).
3
38
125
One of the highlights of the year! Fantastic meeting for all thoracic oncology surgeons as well as trainees and students.
I’m looking forward to the upcoming @AATSHQ #ITSOS2025 meeting in Boston. Always a terrific meeting focused on multi-disciplinary thoracic surgical oncology! Submit your abstract now and register early!
0
1
11
📢Attention #ESTS2025: make plans to join us for #ITSOS2025 led by Program Director and 105th AATS President @JonesDavid2013, September 26-27 in Boston. Abstract submissions are open through June 23. https://t.co/GxWBI6kfR2
0
1
4
Watch Stephen R. Broderick, MD, MPHS (@SBroderickMD), Matthew Bott, MD, & Catherine Shu, MD (@CatherineShuMD) discuss the latest #NSCLC updates following #AATS2025 - to participate, visit: https://t.co/4ZbLuilBi4
0
8
10
Remember to join us May 13, at 7:00 PM EDT, for an #NSCLC online symposium with live Q&A with experts including @SBroderickMD, Matthew Bott, MD & @CatherineShuMD. Submit your questions in advance and follow @PeerView for more #MedEd content! https://t.co/4ZbLuilBi4
#AATS25
0
6
10
This was a lot of fun. Thanks for the invitation and great to meet you @CatherineShuMD!
Thank you to Drs. Broderick, Bott & Shu for an excellent #AATS2025 symposium on immunotherapy in resectable NSCLC! 👏 Couldn’t join in person? Don’t miss the Virtual Symposium on May 13 at 7PM EDT! 🔗 Register here: https://t.co/4ZbLuilBi4
0
8
17
SPONSORED: Join Stephen R. Broderick, MD, MPHS (@SBroderickMD) and colleagues on 5/2 at 11:30 AM PDT during #AATS25 for a #NSCLC #MedEd event. https://t.co/OAGqUGlLFd
#Oncology #LungCancer #LCSM
0
10
10
Great news!
Great day for lung cancer care! Addition of just 3 cycles of nivolumab immunotherapy to standard neoadjuvant chemo leads to improved overall survival for surgically resectable lung cancer! #LCSM
0
0
4
Watch Jessica Donington, MD (@jdoningtonmd), Stephen R. Broderick, MD, MPHS (@SBroderickMD) & Sandip Patel, MD (@PatelOncology) discuss the latest #NSCLC updates from #STS2025 - to participate, visit: https://t.co/5HKBjeA7rS
0
8
16
🎥✨ Hear from @PatelOncology as he shares a preview of our upcoming PeerView symposium at #STS2025! Join us in LA on Jan 25 for expert discussions, interactive sessions, and cutting-edge insights. Don’t miss it—watch the teaser now! 👉 https://t.co/5HKBjezzCk
#MedEd
0
9
11
Now in @JCO_ASCO led by @DrMarkAwad & @MARIANOPROVENCI exploratory arm neoadj ipi nivo for resectable lung cancer in #CM816 w lots of interesting data! Combo neoadj PD1-CTLA4 blockade without chemo likely not a viable strategy for all comers in NSCLC #lcsm
https://t.co/tAtaDNI60p
2
16
58
The annual Sibley Soirée hosted by the Young Professionals Board is Thursday, October 24th at the National Portrait Gallery. The event will support expanded access to care in the @hopkinskimmel at Sibley. https://t.co/3P6d6jB1Dz
0
2
1
Enjoyed making this Answers in CME activity on practical considerations regarding IO in resectable NSCLC with @FordePatrick and @ChaftJamie
Great discussions w Drs. @ChaftJamie & @SBroderickMD on practical immunotherapy in early stage lung cancer! Answers in CME - A Continuous Road to Clinical Improvement: Examining Immunotherapeutic Regimens for Resectable, Early-Stage NSCLC
0
1
7
Thank you for joining us at #ITSOS2024! Thank you to our sponsors, @AstraZeneca, @genentech, @Medtronic, @Intuitive, @JNJMedTech, @Merck, @Regeneron, @BelluckFox, and @bmsnews, and all exhibitors. Save the date for #ITSOS2025. Safe travels home!
0
2
4